Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelius Knabbe

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and postoperative outcome in cardiac surgeryArmin Zittermann, Joachim Kuhn, Jana B Ernst, et al.
Biochemical and Biophysical Research Communications|March 10, 2015
Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serumJoachim Kuhn, Christian Götting, Brendan J Beahm, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesotheliumSylvia Stadlmann, Hans Feichtinger, Gregor Mikuz, et al.
Biochemical and Biophysical Research Communications|March 12, 2019
First description of a compensatory xylosyltransferase I induction observed after an antifibrotic UDP-treatment of normal human dermal fibroblastsBastian Fischer, Thanh-Diep Ly, Doris Hendig, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 4, 2017
Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'Thomas Eller, Tobias Flieder, Vanessa Fox, et al.
Vaccines|May 28, 2022
Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in AdultsJonas Herzberg, Bastian Fischer, Heiko Becher, et al.
Frontiers in Immunology|July 18, 2022
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational StudyJonas Herzberg, Bastian Fischer, Heiko Becher, et al.
Scientific Reports|July 29, 2015
Human xylosyltransferases--mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapyIsabel Faust, Philipp Traut, Frank Nolting, et al.
Biochimie|September 9, 2023
A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activityAnika Kleine, Matthias Kühle, Joachim Kuhn, et al.
Biochemical and Biophysical Research Communications|January 25, 2020
microRNA-145 mediates xylosyltransferase-I induction in myofibroblasts via suppression of transcription factor KLF4Thanh-Diep Ly, Lara Riedel, Bastian Fischer, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and postoperative outcome in cardiac surgeryArmin Zittermann, Joachim Kuhn, Jana B Ernst, et al.
Biochemical and Biophysical Research Communications|March 10, 2015
Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serumJoachim Kuhn, Christian Götting, Brendan J Beahm, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesotheliumSylvia Stadlmann, Hans Feichtinger, Gregor Mikuz, et al.
Biochemical and Biophysical Research Communications|March 12, 2019
First description of a compensatory xylosyltransferase I induction observed after an antifibrotic UDP-treatment of normal human dermal fibroblastsBastian Fischer, Thanh-Diep Ly, Doris Hendig, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 4, 2017
Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'Thomas Eller, Tobias Flieder, Vanessa Fox, et al.
Vaccines|May 28, 2022
Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in AdultsJonas Herzberg, Bastian Fischer, Heiko Becher, et al.
Frontiers in Immunology|July 18, 2022
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational StudyJonas Herzberg, Bastian Fischer, Heiko Becher, et al.
Scientific Reports|July 29, 2015
Human xylosyltransferases--mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapyIsabel Faust, Philipp Traut, Frank Nolting, et al.
Biochimie|September 9, 2023
A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activityAnika Kleine, Matthias Kühle, Joachim Kuhn, et al.
Biochemical and Biophysical Research Communications|January 25, 2020
microRNA-145 mediates xylosyltransferase-I induction in myofibroblasts via suppression of transcription factor KLF4Thanh-Diep Ly, Lara Riedel, Bastian Fischer, et al.
Pageof 18